Articles for tag: depression, DMT, medication, psychiatry, research, risk, treatment

The Clinical Viability of Tryptamine-Based Pharmacotherapy for Major Depressive and Mood Disorders

The field of mental health treatment is witnessing a surge of interest in psychedelic compounds, and Dimethyltryptamine (DMT) is at the forefront of this movement. However, for those following the headlines, it is essential to understand the current status: DMT-based medicines are not yet approved or commercially available. Research into these powerful compounds, particularly the ultra-short-acting analogue 5-MeO-DMT, is still in the mid-stage of clinical testing (Phase 2).   Despite being unapproved, the research is moving quickly. One leading candidate, ...

Partnering with AI in Medicine: Innovations in Diagnostics, Education, and Patient Care

Artificial intelligence (AI) is poised to revolutionise healthcare, offering exciting opportunities to enhance the way doctors work. Tools like DeepSeek, Claude.ai (Amazon), Gemini (Google), Copilot (Microsoft) and Tulu3 are not here to replace medical professionals but to support them. By automating repetitive tasks, simplifying complex information, and uncovering patterns in data, AI can free up valuable time for doctors to focus on what matters most—their patients. While AI is still in its early stages in healthcare, its potential to transform ...

We Need to do Something about Smoking and Mental Health

This article is brazenly one-sided because it is about an addictive killing substance sold legally. The author is unapologetically anti-smoking because tobacco is the only substance labelled as killing that is sold legally for consumer use. Smoking (of tobacco) is normally seen as a physical health problem. This article will show it is a serious mental health problem as well. No evidence has been found to support tobacco smoking as beneficial to mental health for longer than 5 minutes. Unlike ...